We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+1.25%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.06B
AUM Growth
-$119M
Cap. Flow
-$148M
Cap. Flow %
-13.96%
Top 10 Hldgs %
89.1%
Holding
39
New
3
Increased
3
Reduced
4
Closed
5

Top Buys

Rank Stock Value
1
SMMT icon
Summit Therapeutics
SMMT
+$3.11M
2
NTES icon
NetEase
NTES
+$2.04M
3
INFA
Informatica
INFA
+$2M
4
VTNR
Vertex Energy, Inc
VTNR
+$1.41M
5
ALLT icon
Allot
ALLT
+$866K

Top Sells

Rank Stock Value
1
MMYT icon
MakeMyTrip
MMYT
+$9.54M
2
MP icon
MP Materials
MP
+$5.99M
3
CCL icon
Carnival Corporation Ltd
CCL
+$4.49M
4
TRML
Tourmaline Bio
TRML
+$3.82M
5
GS icon
Goldman Sachs
GS
+$2.73M

Sector Composition

Rank Sector Weight
1 Healthcare 70.1%
2 Communication Services 7.91%
3 Financials 7.15%
4 Materials 4.18%
5 Industrials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$25.2B
$705M 66.32%
66,719,779
– –
MP icon
2
MP Materials
MP
$7.35B
$44.5M 4.18%
3,494,158
-381,842
-10% -$5.99M
ECO
3
Okeanis Eco Tankers
ECO
$2.26B
$41.2M 3.87%
1,423,997
– –
GS icon
4
Goldman Sachs
GS
$313B
$33.4M 3.14%
73,833
-6,229
-8% -$2.73M
NXST icon
5
Nexstar Media Group
NXST
$5.6B
$27.5M 2.59%
165,735
– –
NNI icon
6
Nelnet
NNI
$4.79B
$23.2M 2.18%
229,665
– –
ATEX icon
7
Anterix
ATEX
$1.83B
$20M 1.88%
503,941
– –
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.07T
$19.5M 1.83%
47,946
– –
LILAK icon
9
Liberty Latin America Class C
LILAK
$1.5B
$16.8M 1.58%
1,924,414
– –
NYT icon
10
New York Times
NYT
$11.6B
$16.2M 1.53%
316,947
– –
MMYT icon
11
MakeMyTrip
MMYT
$4.67B
$16.1M 1.52%
191,632
-127,776
-40% -$9.54M
ARGX icon
12
argenx
ARGX
$57.4B
$14M 1.31%
32,498
– –
TRML
13
DELISTED
Tourmaline Bio
TRML
$9.15M 0.86%
711,275
-237,091
-25% -$3.82M
ALLT icon
14
Allot
ALLT
$374M
$6.63M 0.62%
2,857,225
+400,000
+16% +$866K
BHVN icon
15
Biohaven
BHVN
$2.16B
$5.9M 0.55%
170,006
– –
IOVA icon
16
Iovance Biotherapeutics
IOVA
$2.23B
$5.44M 0.51%
678,564
– –
SMMT icon
17
Summit Therapeutics
SMMT
$10.9B
$4.49M 0.42%
+575,705
New +$3.11M
VTNR
18
DELISTED
Vertex Energy, Inc
VTNR
$3.9M 0.37%
4,125,000
+1,200,000
+41% +$1.41M
INFA
19
DELISTED
Informatica
INFA
$2.8M 0.26%
90,817
+63,532
+233% +$2M
NTES icon
20
NetEase
NTES
$76.5B
$2.04M 0.19%
+21,394
New +$2.04M
GTN icon
21
Gray Television
GTN
$407M
$1.52M 0.14%
291,452
– –
JD icon
22
JD.com
JD
$40.8B
$834K 0.08%
32,274
– –
SRPT icon
23
Sarepta Therapeutics
SRPT
$1.66B
$492K 0.05%
3,117
– –
VTNR
24
CALL
DELISTED
Vertex Energy, Inc
VTNR
$472K 0.04%
+500,000
New +$587K
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$11.5B
$365K 0.03%
4,429
– –
1
2

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q2 2024 Portfolio in Review

As of Q2 2024, QVT Financial held 39 positions worth $1.06B, down 10% from $1.18B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

QVT Financial withdrew a net $148M in Q2 2024, closing 5 positions and reducing 4 holdings. Its most notable exit was Carnival Corporation Ltd, an estimated $4.49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 64% a quarter earlier, followed by Communication Services and Financials.

Against the trend, QVT Financial opened a new position in Summit Therapeutics worth $4.49M.

  • QVT Financial's largest Q2 2024 buy was Summit Therapeutics: 575,705 shares worth $4.49M.
  • QVT Financial added most to Informatica in Q2 2024, an estimated $2M increase.
  • QVT Financial's biggest Q2 2024 reduction was MakeMyTrip, cutting an estimated $9.54M.
  • QVT Financial fully exited Carnival Corporation Ltd in Q2 2024, selling an estimated $4.49M.
  • QVT Financial's ten largest holdings make up 89% of its $1.06B portfolio in Q2 2024.
  • QVT Financial opened 3 new positions and closed 5 in Q2 2024.
  • QVT Financial's portfolio value fell 10% quarter-over-quarter to $1.06B.

Based on QVT Financial's 13F filing for Q2 2024, filed 14 Aug 2024.